Scentryphar Pesquisa Clínica

Scentryphar Pesquisa Clínica is a Brazilian contract research organization (CRO) specializing in clinical pharmacology and bioequivalence studies. Based in Campinas, the company provides a comprehensive suite of services including Phase I through IV clinical trials, bioanalytical method development, and pharmacokinetic analysis. Scentryphar operates in compliance with international Good Clinical Practice (GCP) and Good Laboratory Practice (GLP) standards, serving both domestic and international pharmaceutical companies. Their expertise particularly focuses on supporting the registration of generic and biosimilar medicines in the Latin American market. The organization maintains advanced laboratory facilities capable of high-throughput bioanalysis using liquid chromatography-mass spectrometry (LC-MS/MS). By offering integrated clinical and analytical solutions, Scentryphar facilitates the drug development process for sponsors seeking regulatory approval from ANVISA and other global health authorities.